Sionna Therapeutics (NASDAQ:SION) Coverage Initiated at Stifel Nicolaus

Equities researchers at Stifel Nicolaus initiated coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage set a “buy” rating and a $32.00 price target on the stock. Stifel Nicolaus’ price target suggests a potential upside of 94.17% from the company’s current price. Separately, […]

Leave a Reply

Your email address will not be published.

Previous post Eli Lilly and Company (NYSE:LLY) Stock Price Up 0.5% Following Analyst Upgrade
Next post Clover Health Investments Sees Unusually High Options Volume (NASDAQ:CLOV)